Search results
April 1 st of each year
- Each title (or volume) of the CFR is revised once each calendar year. A revised Title 21 is issued on approximately April 1 st of each year and is usually available here several months later.
www.fda.gov › medical-devices › medical-device-databasesCode of Federal Regulations - Title 21 - Food and Drugs | FDA
People also ask
What is Title 21?
When does a Title 21 of the Food & Drug Administration come out?
How often does the Food & Drug Administration update the CFR?
How many topics are in the Food & Drug Administration CFR?
Title 21 is the portion of the Code of Federal Regulations that governs food and drugs within the United States for the Food and Drug Administration (FDA), the Drug Enforcement Administration (DEA), and the Office of National Drug Control Policy (ONDCP). It is divided into three chapters: Chapter I — Food and Drug Administration
Dec 22, 2023 · The information on this page is current as of Dec 22, 2023. For the most up-to-date version of CFR Title 21, go to the Electronic Code of Federal Regulations (eCFR). New Search. Help | More...
A revised Title 21 is issued on approximately April 1 st of each year and is usually available here several months later. CFR 21 was downloaded from the files of the Government Printing...
Feb 3, 2021 · Title 21 of the CFR is reserved for rules of the Food and Drug Administration. It is divided into chapters and parts such as food for humans, drugs, food & drugs for animals, cosmetics, medical ...
Aug 7, 2012 · For transfer of functions of Federal Security Administrator to Secretary of Health, Education, and Welfare [now Health and Human Services], and of Food and Drug Administration to Federal Security Agency, see Transfer of Functions notes set out under section 321 of this title. §147. Repeal of inconsistent laws
chapter i—food and drug administration, department of health and human services (subchapters a - l) chapter ii—drug enforcement administration, department of justice (parts 1300 - 1322-1399) chapter iii—office of national drug control policy (parts 1400 - 1403-1499)
The Agency has since pushed that release date back. The FDA has not announced a revised time of release. John Murray, member of the Part 11 Working Group (the team at FDA developing the new Part 11), has publicly stated that the timetable for release is "flexible".
